PortfoliosLab logoPortfoliosLab logo
ISIN
US7437131094
CUSIP
743713109
IPO Date
Feb 24, 2012

Highlights

Market Cap
$1.81B
Enterprise Value
$1.69B
EPS (TTM)
$1.06
PE Ratio
70.27
Total Revenue (TTM)
$546.26M
Gross Profit (TTM)
$245.03M
EBITDA (TTM)
$60.04M
Year Range
$37.39 - $78.52
Target Price
$38.50
ROA (TTM)
3.31%
ROE (TTM)
3.77%

Share Price Chart


Loading charts...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

PRLB Performance Chart

Proto Labs, Inc. (PRLB) is up 47.6% since the beginning of the year. At $75 per share, PRLB is trading 4.9% below its 52-week high of $79. Investors who bought $1,000 worth of PRLB shares 5 years ago would now be looking at an investment worth $845.


Loading charts...

S&P 500 Index

Returns By Period

Proto Labs, Inc. (PRLB) has returned 47.60% so far this year and 98.80% over the past 12 months. Over the last ten years, PRLB has returned 1.02% per year, falling short of the S&P 500 Index benchmark, which averaged 13.66% annually.


Proto Labs, Inc.

1D
-4.58%
1M
16.06%
YTD
47.60%
6M
45.90%
1Y
98.80%
3Y*
31.31%
5Y*
-3.31%
10Y*
1.02%

Benchmark (S&P 500 Index)

1D
-0.74%
1M
4.90%
YTD
10.35%
6M
10.28%
1Y
26.52%
3Y*
20.83%
5Y*
12.30%
10Y*
13.66%
*Multi-year figures are annualized to reflect compound growth (CAGR)

PRLB Monthly Returns History

Based on dividend-adjusted daily data since Feb 24, 2012, PRLB's average daily return is +0.07%, while the average monthly return is +1.35%. At this rate, an investment would double in approximately 4.3 years.

Historically, 52% of months were positive and 48% were negative. The best month was Nov 2023 with a return of +53.3%, while the worst month was Feb 2021 at -31.2%. The longest winning streak lasted 14 consecutive months, and the longest losing streak was 5 months.

On a daily basis, PRLB closed higher 51% of trading days. The best single day was Nov 1, 2024 with a return of +38.7%, while the worst single day was Nov 4, 2022 at -31.1%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20264.07%17.91%-8.15%13.66%16.90%-1.44%47.60%
20256.75%-4.43%-12.14%0.34%5.18%8.27%7.69%15.51%0.44%-0.54%2.13%-0.45%29.42%
2024-7.37%0.94%-1.87%-14.74%1.61%-0.26%12.72%-12.18%-3.96%-6.71%50.33%-5.10%0.33%
202319.86%2.75%5.44%-13.21%6.92%13.65%-5.18%-11.01%-10.51%-10.57%53.32%7.62%52.60%
2022-2.28%12.06%-5.92%-19.45%13.10%-0.73%2.19%-21.46%-5.13%4.83%-30.56%-3.73%-50.28%
202138.07%-31.22%-16.43%-7.96%-20.23%2.70%-14.83%-5.15%-10.19%-10.20%-16.20%2.45%-66.53%

Benchmark Metrics

Proto Labs, Inc. has an annualized alpha of 0.92%, beta of 1.25, and R2 of 0.20 versus S&P 500 Index. Calculated based on daily prices since February 27, 2012.

  • This stock participated in 112.84% of S&P 500 Index downside but only 85.82% of its upside - more exposed to losses than it benefited from rallies.
  • R2 of 0.20 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
0.92%
Beta
1.25
0.20
Upside Capture
85.82%
Downside Capture
112.84%

Return for Risk

Risk / Return Rank

PRLB ranks 91 for risk / return — in the top 91% of stocks on our site. This means strong returns relative to risk — exactly what professional investors look for. Well-suited for investors who want to maximize return per unit of risk.


PRLB Risk / Return Rank: 9191
Overall Rank
PRLB Sharpe Ratio Rank: 9090
Sharpe Ratio Rank
PRLB Sortino Ratio Rank: 9292
Sortino Ratio Rank
PRLB Omega Ratio Rank: 9090
Omega Ratio Rank
PRLB Calmar Ratio Rank: 9191
Calmar Ratio Rank
PRLB Martin Ratio Rank: 9292
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Proto Labs, Inc. (PRLB) and compare them to S&P 500 Index.


PRLBBenchmarkDifference

Sharpe ratio

Return per unit of total volatility

2.22

2.24

-0.02

Sortino ratio

Return per unit of downside risk

3.50

3.07

+0.42

Omega ratio

Gain probability vs. loss probability

1.44

1.41

+0.03

Calmar ratio

Return relative to maximum drawdown

5.09

2.93

+2.17

Martin ratio

Return relative to average drawdown

14.93

13.52

+1.41

Dividends

Dividend History


Proto Labs, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading charts...

Worst Drawdowns

The table below displays the maximum drawdowns of the Proto Labs, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Proto Labs, Inc. was 91.22%, occurring on Nov 9, 2022. The portfolio has not yet recovered.

The current Proto Labs, Inc. drawdown is 70.31%.


Related event

Drawdown

Fall

Recovery

Underwater

Bear market2022
-91.22%Nov 2022
1y 9mo
5y 4moJan 2021 - now
COVID crash2020
-60.84%Mar 2020
1y 6mo9mo 7d
2y 3moSep 2018 - Dec 2020
2016 bear market2016
-49.77%Nov 2016
3y 9d11mo 28d
4y 2dOct 2013 - Oct 2017
2012 bear market2012
-27.76%Oct 2012
2mo 21d2mo 25d
5mo 16dAug 2012 - Jan 2013
2012 bear market2012
-25.59%Jun 2012
1mo 28d1mo 3d
3mo 1dMay 2012 - Aug 2012

Drawdown Indicators


PRLBBenchmarkDifference

Max Drawdown

Largest peak-to-trough decline

-91.22%

-56.78%

-34.44%

Max Drawdown (1Y)

Largest decline over 1 year

-19.51%

-9.10%

-10.41%

Max Drawdown (3Y)

Largest decline over 3 years

-35.14%

-18.90%

-16.24%

Max Drawdown (5Y)

Largest decline over 5 years

-77.19%

-25.43%

-51.76%

Max Drawdown (10Y)

Largest decline over 10 years

-91.22%

-33.92%

-57.30%

Current Drawdown

Current decline from peak

-70.31%

-0.74%

-69.57%

Average Drawdown

Average peak-to-trough decline

-43.22%

-10.72%

-32.50%

Ulcer Index

Depth and duration of drawdowns from previous peaks

6.64%

1.97%

+4.67%

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading charts...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Proto Labs, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Proto Labs, Inc. is priced in the market compared to other companies in the Metal Fabrication industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PE Ratio

The chart displays the Price-to-Earnings (P/E) ratio for PRLB, comparing it with other companies in the Metal Fabrication industry. Currently, PRLB has a P/E ratio of 70.3. This P/E ratio is significantly higher than those of industry peers. This could indicate that the stock is overvalued or that investors expect strong future growth.

PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for PRLB relative to other companies in the Metal Fabrication industry. Currently, PRLB has a P/S ratio of 3.3. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for PRLB in comparison with other companies in the Metal Fabrication industry. Currently, PRLB has a P/B value of 2.7. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
Portfolio Analyzer

Build a portfolio with PRLB

Add Proto Labs, Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Analyzer with PRLB